Healthcare provider profile · identity verified

Thomas Dillard Gary, M.D.

Family Practice · BLAIRSVILLE, GA · NPI 1093891921

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	614	181
Rosuvastatin Calcium	Rosuvastatin Calcium	560	165
Levothyroxine Sodium	Levothyroxine Sodium	485	121
Amlodipine Besylate	Amlodipine Besylate	412	115
Lisinopril	Lisinopril	407	123
Gabapentin	Gabapentin	338	82
Omeprazole	Omeprazole	313	94
Sertraline Hcl	Sertraline Hcl	268	63
Tamsulosin Hcl	Tamsulosin Hcl	233	63
Losartan Potassium	Losartan Potassium	215	68
Metformin Hcl	Metformin Hcl	209	59
Trazodone Hcl	Trazodone Hcl	207	60
Prednisone	Prednisone	197	157
Metoprolol Tartrate	Metoprolol Tartrate	179	55
Hydrochlorothiazide	Hydrochlorothiazide	177	53
Tramadol Hcl	Tramadol Hcl	155	46
Pantoprazole Sodium	Pantoprazole Sodium	154	47
Meloxicam	Meloxicam	145	39
Eliquis	Apixaban	139	34
Potassium Chloride	Potassium Chloride	134	40
Metformin Hcl Er	Metformin Hcl	129	42
Celecoxib	Celecoxib	126	35
Simvastatin	Simvastatin	123	38
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	113	33
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	112	31
Metoprolol Succinate	Metoprolol Succinate	112	33
Ezetimibe	Ezetimibe	99	28
Furosemide	Furosemide	98	26
Fluticasone Propionate	Fluticasone Propionate	88	38
Atenolol	Atenolol	86	24
Famotidine	Famotidine	84	31
Allopurinol	Allopurinol	82	28
Ropinirole Hcl	Ropinirole Hcl	82	19
Albuterol Sulfate Hfa	Albuterol Sulfate	80	40
Montelukast Sodium	Montelukast Sodium	78	22
Duloxetine Hcl	Duloxetine Hcl	77	19
Buspirone Hcl	Buspirone Hcl	68	22
Jardiance	Empagliflozin	68	22
Pregabalin	Pregabalin	68	25
Amitriptyline Hcl	Amitriptyline Hcl	67	14
Azithromycin	Azithromycin	61	57
Carvedilol	Carvedilol	61	19
Fluoxetine Hcl	Fluoxetine Hcl	58	17
Donepezil Hcl	Donepezil Hcl	56	16
Finasteride	Finasteride	55	16
Spironolactone	Spironolactone	55	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	54	30
Baclofen	Baclofen	53	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	53	19
Amoxicillin	Amoxicillin	52	44
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	51	14
Clopidogrel	Clopidogrel Bisulfate	50	20
Mirtazapine	Mirtazapine	50	suppressed
Pravastatin Sodium	Pravastatin Sodium	49	17
Diclofenac Sodium	Diclofenac Sodium	45	11
Nystatin	Nystatin	45	12
Alendronate Sodium	Alendronate Sodium	44	13
Carbidopa-Levodopa	Carbidopa/Levodopa	44	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	44	31
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	40	13
Paroxetine Hcl	Paroxetine Hcl	40	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	39	suppressed
Lovastatin	Lovastatin	36	suppressed
Symbicort	Budesonide/Formoterol Fumarate	36	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	35	suppressed
Chlorthalidone	Chlorthalidone	33	11
Gemfibrozil	Gemfibrozil	33	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	33	suppressed
Warfarin Sodium	Warfarin Sodium	33	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	31	30
Citalopram Hbr	Citalopram Hydrobromide	30	11
Olmesartan Medoxomil	Olmesartan Medoxomil	30	suppressed
Ondansetron Odt	Ondansetron	30	16
Quetiapine Fumarate	Quetiapine Fumarate	30	suppressed
Sucralfate	Sucralfate	30	suppressed
Synthroid	Levothyroxine Sodium	30	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	29	26
Glipizide	Glipizide	29	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	29	suppressed
Methimazole	Methimazole	29	suppressed
Alprazolam	Alprazolam	28	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	28	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	27	18
Clonazepam	Clonazepam	26	suppressed
Ramipril	Ramipril	26	suppressed
Ozempic	Semaglutide	25	suppressed
Azathioprine	Azathioprine	24	suppressed
Bupropion Xl	Bupropion Hcl	24	suppressed
Cefdinir	Cefdinir	24	24
Trulicity	Dulaglutide	24	suppressed
Xarelto	Rivaroxaban	24	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	23	21
Nitrofurantoin	Nitrofurantoin Macrocrystal	23	12
Levetiracetam	Levetiracetam	22	suppressed
Divalproex Sodium	Divalproex Sodium	21	suppressed
Fenofibrate	Fenofibrate	21	suppressed
Irbesartan	Irbesartan	21	suppressed
Azelastine Hcl	Azelastine Hcl	20	suppressed
Estradiol	Estradiol	20	suppressed
Risperidone	Risperidone	20	suppressed
Glimepiride	Glimepiride	19	suppressed
Diazepam	Diazepam	18	suppressed
Fenofibrate	Fenofibrate,micronized	18	suppressed
Fluconazole	Fluconazole	18	17
Ipratropium Bromide	Ipratropium Bromide	18	suppressed
Clonidine	Clonidine	17	suppressed
Dutasteride	Dutasteride	17	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	17	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	17	suppressed
Labetalol Hcl	Labetalol Hcl	17	suppressed
Lansoprazole	Lansoprazole	17	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Propranolol Hcl	Propranolol Hcl	17	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	17	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	16	16
Calcitriol	Calcitriol	16	suppressed
Entresto	Sacubitril/Valsartan	16	suppressed
Memantine Hcl	Memantine Hcl	16	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	16	suppressed
Synjardy Xr	Empagliflozin/Metformin Hcl	16	suppressed
Terazosin Hcl	Terazosin Hcl	16	suppressed
Tizanidine Hcl	Tizanidine Hcl	16	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	16	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	16	suppressed
Acyclovir	Acyclovir	15	suppressed
Enalapril Maleate	Enalapril Maleate	15	suppressed
Farxiga	Dapagliflozin Propanediol	15	suppressed
Glipizide Er	Glipizide	15	suppressed
Lorazepam	Lorazepam	15	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	15	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	14	suppressed
Ibuprofen	Ibuprofen	14	suppressed
Oxycontin	Oxycodone Hcl	14	suppressed
Atomoxetine Hcl	Atomoxetine Hcl	13	suppressed
Bupropion Hcl Sr	Bupropion Hcl	13	suppressed
Divalproex Sodium Er	Divalproex Sodium	13	suppressed
Enbrel Sureclick	Etanercept	13	suppressed
Januvia	Sitagliptin Phosphate	13	suppressed
Nifedipine Er	Nifedipine	13	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	13	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	13	suppressed
Torsemide	Torsemide	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	suppressed
Xigduo Xr	Dapaglifloz Propaned/Metformin	13	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	12	suppressed
Bupropion Hcl	Bupropion Hcl	12	suppressed
Felbamate	Felbamate	12	suppressed
Flecainide Acetate	Flecainide Acetate	12	suppressed
Hydralazine Hcl	Hydralazine Hcl	12	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	12	suppressed
Lamotrigine	Lamotrigine	12	suppressed
Meclizine Hcl	Meclizine Hcl	12	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	12	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	12	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	11	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	11	suppressed
Oxycodone Hcl	Oxycodone Hcl	11	suppressed
Tadalafil	Tadalafil	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error